Image

The DefiPace Study

The DefiPace Study

Recruiting
60 years and older
All
Phase N/A

Powered by AI

Overview

Prospective, non-interventional, multi-center, international registry in two phases in consecutive patients undergoing elective cardiac surgery.

The DefiPace registry is designed in two phases

  1. to document the standard of care in 50 patients with atrial fibrillation (AF)
  2. to assess the treatment and outcomes of patients with post-operative atrial fibrilllation using low-energy cardioversion and subsequent bi-atrial pacing in clinical practice in 100 patients

Description

Phase A Approximately 150 consecutive patients undergoing elective cardiac surgery (bypass and / or valve surgery)

  • Data regarding standard of care post-operative pacing and treatment of POAF, if applicable, will be collected from time of surgery until discharge
  • No use of an external bi-atrial pacing device
  • No use of Defipace
  • In-hospital data will be collected for all patients
  • Patients that developed POAF (n=50) will be followed-up with a phone call 30 days after surgery.

Phase B Approximately 300 consecutive patients undergoing elective cardiac surgery (bypass and / or valve surgery) with planned TMA implantation

  • In-hospital data will be collected for all patients
  • Use of the DefiPace system for the treatment (low-energy cardioversion) and post-operative prevention (bi-atrial pacing) of POAF will be documented (n=100). These patients will be followed-up with a phone call 30 days after surgery

Eligibility

Inclusion Criteria:

  • Patient is scheduled to undergo elective open chest cardiac surgery (bypass and / or valve surgery)
  • Patient with isolated bypass surgery is at least 70 years old
  • Patient with valve surgery is at least 60 years old
  • Patient provides written informed consent prior to the procedure
  • Phase B only: patient is scheduled for TMA implantation during the elective cardiac surgery and is potentially eligible for DefiPace use

Exclusion Criteria:

  • Permanent AF at hospital admission
  • Permanent pacemaker/defibrillator, other intra-cardiac active implanted electronic devices
  • Minimally-invasive surgery
  • Recent stroke within the last 3 months
  • A history of or current endocarditis

Study details
    Post-operative Atrial Fibrillation POAF

NCT04804748

Institut für Pharmakologie und Präventive Medizin

26 January 2024

Step 1 Get in touch with the nearest study center
We have submitted the contact information you provided to the research team at {{SITE_NAME}}. A copy of the message has been sent to your email for your records.
Would you like to be notified about other trials? Sign up for Patient Notification Services.
Sign up

Send a message

Enter your contact details to connect with study team

Investigator Avatar

Primary Contact

  Other languages supported:

First name*
Last name*
Email*
Phone number*
Other language

FAQs

Learn more about clinical trials

What is a clinical trial?

A clinical trial is a study designed to test specific interventions or treatments' effectiveness and safety, paving the way for new, innovative healthcare solutions.

Why should I take part in a clinical trial?

Participating in a clinical trial provides early access to potentially effective treatments and directly contributes to the healthcare advancements that benefit us all.

How long does a clinical trial take place?

The duration of clinical trials varies. Some trials last weeks, some years, depending on the phase and intention of the trial.

Do I get compensated for taking part in clinical trials?

Compensation varies per trial. Some offer payment or reimbursement for time and travel, while others may not.

How safe are clinical trials?

Clinical trials follow strict ethical guidelines and protocols to safeguard participants' health. They are closely monitored and safety reviewed regularly.
Add a private note
  • abc Select a piece of text.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.